share_log

BRIEF-Mateon Therapeutics Inc Says First Patient Enrolled This Week In Its Phase IV Study

BRIEF-Mateon Therapeutics Inc Says First Patient Enrolled This Week In Its Phase IV Study

Brief-Mateon治疗公司表示,本周第一名患者登记参加其IV期研究
Reuters ·  2020/10/07 07:43

Oct 7 (Reuters) - Mateon Therapeutics Inc MATN.PK :

路透10月7日电-Mateon治疗公司MATN.PK:

* MATEON THERAPEUTICS INC - ANNOUNCED FIRST PATIENT ENROLLED THIS WEEK IN ITS PHASE IV STUDY ARTI-19

*MATEON治疗公司-本周宣布第一名患者参加其第四阶段研究ARTI-19

* MATEON THERAPEUTICS INC - TOP-LINE DATA FROM ARTI-19 IS EXPECTED BY END OF 4Q20

*MATEON治疗公司-ARTI-19的一线数据预计将在20年第四季度末公布

Source text for Eikon: Further company coverage:

Eikon的源文本:进一步的公司报道:

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发